Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Dermatology

Clinical Pharmacology

Psoriatic arthritis incidence among patients receiving biologic medications for psoriasis: A nested case control study

Arthritis & Rheumatology | Aug 27, 2021 Clinical Pharmacology

Hedgehog inhibitors with and without adjunctive therapy in treatment of locally advanced basal cell carcinoma

International Journal of Dermatology | Aug 26, 2021 Clinical Pharmacology

Safety of Janus kinase (JAK) inhibitors in the short-term treatment of atopic dermatitis

International Journal of Dermatology | Aug 26, 2021 Clinical Pharmacology

Efficacy and safety of adalimumab in conjunction with surgery in moderate to severe hidradenitis suppurativa: The SHARPS randomized clinical trial

JAMA | Aug 24, 2021 Clinical Pharmacology

Efficacy and safety of abrocitinib in combination with topical therapy in adolescents with moderate-to-severe atopic dermatitis: The JADE TEEN randomized clinical trial

JAMA | Aug 23, 2021 Clinical Pharmacology

Direct comparison of risankizumab and fumaric acid esters in systemic therapy–naïve patients with moderate-to-severe plaque psoriasis: A randomized controlled trial

British Journal of Dermatology | Aug 21, 2021 Clinical Pharmacology

Abrocitinib induction, randomized withdrawal, and retreatment in patients with moderate to severe atopic dermatitis: Results from the JADE REGIMEN phase 3 trial

Journal of the American Academy of Dermatology | Aug 20, 2021 Clinical Pharmacology

Efficacy and safety of tildrakizumab in patients with active psoriatic arthritis: Results of a randomised, double-blind, placebo-controlled, multiple-dose, 52-week phase IIb study

Annals of Rheumatic Diseases | Aug 18, 2021 Clinical Pharmacology

Real-world effectiveness of adalimumab in patients with moderate to severe hidradenitis suppurativa: The 1-year SOLACE study

Journal of the European Academy of Dermatology and Venereology | Aug 16, 2021 Clinical Pharmacology

Biologics modulate antinuclear antibodies, immunoglobulin E, and eosinophil counts in psoriasis patients

The Journal of Dermatology | Aug 12, 2021 Clinical Pharmacology

« Prev 1 … 12 13 14 15 16 … 92 Next »

Psoriatic arthritis incidence among patients receiving biologic medications for psoriasis: A nested case control study

Hedgehog inhibitors with and without adjunctive therapy in treatment of locally advanced basal cell carcinoma

Safety of Janus kinase (JAK) inhibitors in the short-term treatment of atopic dermatitis

Efficacy and safety of adalimumab in conjunction with surgery in moderate to severe hidradenitis suppurativa: The SHARPS randomized clinical trial

Efficacy and safety of abrocitinib in combination with topical therapy in adolescents with moderate-to-severe atopic dermatitis: The JADE TEEN randomized clinical trial

Direct comparison of risankizumab and fumaric acid esters in systemic therapy–naïve patients with moderate-to-severe plaque psoriasis: A randomized controlled trial

Abrocitinib induction, randomized withdrawal, and retreatment in patients with moderate to severe atopic dermatitis: Results from the JADE REGIMEN phase 3 trial

Efficacy and safety of tildrakizumab in patients with active psoriatic arthritis: Results of a randomised, double-blind, placebo-controlled, multiple-dose, 52-week phase IIb study

Real-world effectiveness of adalimumab in patients with moderate to severe hidradenitis suppurativa: The 1-year SOLACE study

Biologics modulate antinuclear antibodies, immunoglobulin E, and eosinophil counts in psoriasis patients

MD Clip on Recent Advances in Lipid Management with Dr Gopinath

Article: Anti-Inflammatory Diets for Pain and Arthritis Management

Article on Strategies to Reduce Antibiotic Misuse and Address Antimicrobial Resistance

The 1 food geriatricians avoid to live a long, healthy life

Many young adults have high long-term risk for cardiovascular disease, study finds

Psoriatic arthritis incidence among patients receiving biologic medications for psoriasis: A nested case control study

Hedgehog inhibitors with and without adjunctive therapy in treatment of locally advanced basal cell carcinoma

Safety of Janus kinase (JAK) inhibitors in the short-term treatment of atopic dermatitis

Efficacy and safety of adalimumab in conjunction with surgery in moderate to severe hidradenitis suppurativa: The SHARPS randomized clinical trial

Efficacy and safety of abrocitinib in combination with topical therapy in adolescents with moderate-to-severe atopic dermatitis: The JADE TEEN randomized clinical trial

Direct comparison of risankizumab and fumaric acid esters in systemic therapy–naïve patients with moderate-to-severe plaque psoriasis: A randomized controlled trial

Abrocitinib induction, randomized withdrawal, and retreatment in patients with moderate to severe atopic dermatitis: Results from the JADE REGIMEN phase 3 trial

Efficacy and safety of tildrakizumab in patients with active psoriatic arthritis: Results of a randomised, double-blind, placebo-controlled, multiple-dose, 52-week phase IIb study

Real-world effectiveness of adalimumab in patients with moderate to severe hidradenitis suppurativa: The 1-year SOLACE study

Biologics modulate antinuclear antibodies, immunoglobulin E, and eosinophil counts in psoriasis patients

MD Clip on Recent Advances in Lipid Management with Dr Gopinath

Article: Anti-Inflammatory Diets for Pain and Arthritis Management

Article on Strategies to Reduce Antibiotic Misuse and Address Antimicrobial Resistance

The 1 food geriatricians avoid to live a long, healthy life

Many young adults have high long-term risk for cardiovascular disease, study finds

Select Specialty

Select Topic